Elmind Capital, LP — 13F Holdings

2026 Q3  ·  35 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Elmind Capital, LP maintained a portfolio of 35 distinct positions. They heavily accumulated shares in AMYLYX PHARMACEUTICALS INC, increasing the position by 698.9%. The fund also reduced its exposure to COGENT BIOSCIENCES INC by 26.0%.
Position History hover any row below to update
Loading…
Elmind Capital, LP New York, NY Hedge Fund AUM $404M
PCA Score Concentration Risk
Risk ENB
Total Positions
35
Quarter
2026 Q3
Top Holding
CLDX (8.9%)
Top 10 Concentration
65.1%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-35 of 35

Elmind Capital, LP Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
CLDX
CELLDEX THERAPE...
Healthcare 8.91% 9.25% #1 2
Prev: #3
7.6
—
120,000 12.1%
P
S
1,110,000 $35,975,100
$28.86 -2.9%
$32.41 -13.5%
2025 Q4 13F Filing 2026-09-30 2026-11-16
LEGN
LEGEND BIOTECH ...
Healthcare 7.73% 4.14% #2 9
Prev: #11
7.6
—
999,107 175.1%
P
S
1,569,676 $31,220,856
$23.16 -30.4%
$19.89 -19.0%
2026 Q2 13F Filing 2026-09-30 2026-11-16
SNDX
SYNDAX PHARMACE...
Healthcare 7.47% 10.19% #3 1
Prev: #2
4.5
—
-250,000 -13.5%
P
S
1,605,000 $30,174,000
$21.01 -56.2%
$18.80 -51.1%
2025 Q4 13F Filing 2026-09-30 2026-11-16
COGT
COGENT BIOSCIEN...
Healthcare 6.87% 11.38% #4 3
Prev: #1
3.2
—
-303,998 -26.0%
P
S
866,742 $27,753,079 2025 Q4 13F Filing 2026-09-30 2026-11-16
RLAY
RELAY THERAPEUT...
Healthcare 6.55% 6.89% #5 1
Prev: #4
4.1
—
no change no change
P
S
1,465,279 $26,448,286 2025 Q4 13F Filing 2026-09-30 2026-11-16
AMLX
AMYLYX PHARMACE...
Healthcare 6.45% 0.51% #6 22
Prev: #28
5.6
—
782,760 698.9%
P
S
894,760 $26,037,516 2025 Q4 13F Filing 2026-09-30 2026-11-16
VRDN
VIRIDIAN THERAP...
Healthcare 6.25% 4.55% #7 1
Prev: #8
5.0
—
240,000 24.4%
P
S
1,224,931 $25,221,329 2025 Q4 13F Filing 2026-09-30 2026-11-16
PCVX
VAXCYTE INC
Healthcare 5.25% 6.61% #8 3
Prev: #5
2.6
—
-80,000 -17.7%
P
S
372,340 $21,186,146 2025 Q4 13F Filing 2026-09-30 2026-11-16
URGN
UROGEN PHARMA L...
Healthcare 4.94% 1.11% #9 13
Prev: #22
5.0
—
371,100 309.2%
P
S
491,100 $19,953,393 2025 Q4 13F Filing 2026-09-30 2026-11-16
TVTX
TRAVERE THERAPE...
Healthcare 4.70% 4.18% #10
Prev: #10
3.9
—
30,000 10.3%
P
S
322,600 $18,994,688 2025 Q4 13F Filing 2026-09-30 2026-11-16
CGEM
CULLINAN THERAP...
Healthcare 3.66% 3.16% #11 2
Prev: #13
4.0
—
272,792 39.5%
P
S
962,792 $14,778,857 2025 Q4 13F Filing 2026-09-30 2026-11-16
PHVS
PHARVARIS N V
Healthcare 3.58% 4.57% #12 5
Prev: #7
1.9
—
-70,000 -13.3%
P
S
455,750 $14,456,390 2025 Q4 13F Filing 2026-09-30 2026-11-16
VERA
VERA THERAPEUTI...
Healthcare 3.49% 4.71% #13 7
Prev: #6
2.4
—
no change no change
P
S
436,518 $14,095,166 2025 Q4 13F Filing 2026-09-30 2026-11-16
CTMX
CYTOMX THERAPEU...
Healthcare 3.06% 4.29% #14 5
Prev: #9
2.2
—
no change no change
P
S
4,550,000 $12,376,000 2025 Q4 13F Filing 2026-09-30 2026-11-16
BEAM
BEAM THERAPEUTI...
Healthcare 2.88% 4.11% #15 3
Prev: #12
2.2
—
no change no change
P
S
476,338 $11,646,464 2025 Q4 13F Filing 2026-09-30 2026-11-16
NRIX
NURIX THERAPEUT...
Healthcare 2.70% 2.80% #16 2
Prev: #14
2.1
—
no change no change
P
S
460,000 $10,906,600 2025 Q4 13F Filing 2026-09-30 2026-11-16
SMMT
SUMMIT THERAPEU...
Healthcare 2.07% 1.81% #17
Prev: #17
1.8
—
no change no change
P
S
493,820 $8,350,496 2026 Q2 13F Filing 2026-09-30 2026-11-16
UTHR
UNITED THERAPEU...
Healthcare 2.01% 2.04% #18 2
Prev: #16
1.8
—
no change no change
P
S
15,000 $8,128,350 2025 Q4 13F Filing 2026-09-30 2026-11-16
IMCR
IMMUNOCORE HLDG...
Healthcare 1.92% 0.65% #19 8
Prev: #27
3.8
—
175,000 215.7%
P
S
256,143 $7,758,571 2025 Q4 13F Filing 2026-09-30 2026-11-16
KRYS
KRYSTAL BIOTECH...
Healthcare 1.81% 2.05% #20 5
Prev: #15
1.7
—
no change no change
P
S
22,000 $7,316,320 2025 Q4 13F Filing 2026-09-30 2026-11-16
ALMS
ALUMIS INC
Healthcare 1.37% 0.92% #21 3
Prev: #24
3.5
—
619,560 476.6%
P
S
749,560 $5,539,248 2026 Q1 13F Filing 2026-09-30 2026-11-16
BCRX
BIOCRYST PHARMA...
Healthcare 1.07% 1.31% #22 3
Prev: #19
1.4
—
no change no change
P
S
520,000 $4,331,600 2025 Q4 13F Filing 2026-09-30 2026-11-16
STRO
SUTRO BIOPHARMA...
Healthcare 0.91% 0.27% #23 9
Prev: #32
3.4
—
196,228 612.5%
P
S
228,265 $3,677,349 2026 Q2 13F Filing 2026-09-30 2026-11-16
MBX
MBX BIOSCIENCES...
Healthcare 0.89% 1.26% #24 4
Prev: #20
0.4
—
-30,000 -33.0%
P
S
61,000 $3,575,820 2025 Q4 13F Filing 2026-09-30 2026-11-16
DBVT
DBV TECHNOLOGIE...
Healthcare 0.77% 1.09% #25 2
Prev: #23
1.3
—
no change no change
P
S
265,000 $3,116,400 2026 Q1 13F Filing 2026-09-30 2026-11-16
SUPN
SUPERNUS PHARMA...
Healthcare 0.75% 0.82% #26 1
Prev: #25
1.3
—
no change no change
P
S
70,000 $3,012,800 2025 Q4 13F Filing 2026-09-30 2026-11-16
BMRN
BIOMARIN PHARMA...
Healthcare 0.70% 0.68% #27 1
Prev: #26
1.3
—
no change no change
P
S
47,000 $2,820,000 2025 Q4 13F Filing 2026-09-30 2026-11-16
SEPN
SEPTERNA INC
Healthcare 0.48% 0.42% #28 2
Prev: #30
1.2
—
no change no change
P
S
49,444 $1,934,744 2026 Q2 13F Filing 2026-09-30 2026-11-16
ALEC
ALECTOR INC
Healthcare 0.42% 0.45% #29
Prev: #29
0.7
—
15,902 1.8%
P
S
915,902 $1,694,419 2025 Q4 13F Filing 2026-09-30 2026-11-16
DSGN
DESIGN THERAPEU...
Healthcare 0.34% 0.39% #30 1
Prev: #31
1.1
—
no change no change
P
S
107,900 $1,356,303 2025 Q4 13F Filing 2026-09-30 2026-11-16
ENGN
ENGENE THERAPEU...
Healthcare 0.00% 0.09%
Sold All 😨
(Was: #35)
0.0
—
-210,000 -100.0%
CLOSED
— $— 2025 Q4 13F Filing 2026-09-30 2026-11-16
TYRA
TYRA BIOSCIENCE...
Healthcare 0.00% 0.16%
Sold All 😨
(Was: #34)
0.0
—
-20,000 -100.0%
CLOSED
— $— 2025 Q4 13F Filing 2026-09-30 2026-11-16
WVE
WAVE LIFE SCIEN...
Healthcare 0.00% 0.26%
Sold All 😨
(Was: #33)
0.0
—
-177,846 -100.0%
CLOSED
— $— 2025 Q4 13F Filing 2026-09-30 2026-11-16
PTGX
PROTAGONIST THE...
Healthcare 0.00% 1.17%
Sold All 😨
(Was: #21)
0.0
—
-38,000 -100.0%
CLOSED
— $— 2025 Q4 13F Filing 2026-09-30 2026-11-16
INSM
INSMED INC
Healthcare 0.00% 1.74%
Sold All 😨
(Was: #18)
0.0
—
-65,000 -100.0%
CLOSED
— $— 2026 Q2 13F Filing 2026-09-30 2026-11-16
Showing 1-35 of 35 holdings

Unlock Full Elmind Capital, LP Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →